HomeVACBF • OTCMKTS
add
Nykode Therapeutics ASA
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 8.09M | -37.20% |
Net income | -8.00M | -18.35% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -7.91M | -36.28% |
Effective tax rate | 0.61% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 60.29M | -47.76% |
Total assets | 99.96M | -34.87% |
Total liabilities | 8.42M | -51.25% |
Total equity | 91.54M | — |
Shares outstanding | 326.55M | — |
Price to book | 1.36 | — |
Return on assets | -19.67% | — |
Return on capital | -20.61% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -8.00M | -18.35% |
Cash from operations | -5.17M | 54.65% |
Cash from investing | 2.15M | -33.82% |
Cash from financing | -322.00K | 34.02% |
Net change in cash | -3.64M | 60.51% |
Free cash flow | -701.38K | 90.58% |
About
Founded
2006
Website
Employees
59
